Identification of human CD4+ T-cell epitopes on the VP1 capsid protein of enterovirus 71

Viral Immunology

Volumn 21, Issue 2, 2008, Pages 215-224

  Foo, Damian Guang Wei ^a   Macary, Paul A ^a   Alonso, Sylvie ^a,c   Poh, Chit Laa ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^c Centre for Life Sciences   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SYNTHETIC PEPTIDE;

ADAPTIVE IMMUNITY; ALGORITHM; ALLELE; BINDING AFFINITY; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CELL STIMULATION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTEROVIRUS 71; HLA SYSTEM; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE;

ADULT; ALGORITHMS; AMINO ACID SEQUENCE; CAPSID PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; COMPUTATIONAL BIOLOGY; ENTEROVIRUS A, HUMAN; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; FEMALE; HUMANS; INTERFERONS; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; MALE; MOLECULAR SEQUENCE DATA; PEPTIDES; SOFTWARE;

HUMAN ENTEROVIRUS 71; MIRIDAE;

EID: 45749156795     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2007.0089     Document Type: Conference Paper

References (47)

1. Arend SM, Geluk A, van Meijgaarden KE, van Dissel JT, Theisen M, Andersen P, and Ottenhoff TH: Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides. Infect Immun 2000;68:3314-3321.
2. Barnard DL: Current status of anti-picornavirus therapies. Curr Pharm Des 2006;12:1379-1390.
3. Barnard DL, Hubbard VD, Smee DF, Sidwell RW, Watson KG, Tucker SP, and Reece PA: In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: novel capsid-binding inhibitors with potent antipicornavirus activity. Antimicrob Agents Chemother 2004;48:1766-1772.
4. Beck MA, and Tracy SM: Murine cell-mediated immune response recognizes an enterovirus group-specific antigen( s). J Virol 1989;63:4148-4156.
5. Blomberg J, Lycke E, Ahlfors K, Johnsson T, Wolontis S, and Von Zeipel G: Letter: New enterovirus type associated with epidemic of aseptic meningitis and/or hand, foot, and mouth disease. Lancet 1974;13:112.
6. Cello J, Samuelson A, Stålhandske P, Svennerholm B, Jeansson S, and Forsgren M: Identification of group-common linear epitopes in structural and nonstructural proteins of enteroviruses by using synthetic peptides. J Clin Microbiol 1993;31:911-916.
7. Cello J, Strannegård, and Svennerholm B: A study of the cellular immune response to enteroviruses in humans: identification of cross-reactive T-cell epitopes on the structural proteins of enteroviruses. J Gen Virol 1996;77:2097-2108.
8. Chen HF, Chang MH, Chiang BL, and Jeng ST: Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71. Vaccine 2006;24:2944-2951.
9. Chiu CH, Chu C, He CC, and Lin TY: Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71. Microbes Infect 2006;8:1671-1678.
10. Chumakov M, Voroshilova M, Shindarov L, et al.: Enterovirus 71 isolated from cases of epidemic poliomyelitislike disease in Bulgaria. Arch Virol 1979;60:329-340.
11. Collen T, Pullen L, and Doel TR: T cell-dependent induction of antibody against foot-and-mouth disease virus in a mouse model. J Gen Virol 1989;70:395-403.
12. Collen T, and Doel TR: Heterotypic recognition of footand-mouth disease virus by cattle lymphocytes. J Gen Virol 1990;71:309-315.
13. De Groot AS, Jesdale BM, Szu E, Schafer JR, Chicz RM, and Deocampo G: An interactive Web site providing major histocompatibility ligand predictions: application to HIV research. AIDS Res Hum Retroviruses 1997;13:529-531.
14. Foo DG, Alonso S, Chow VT, and Poh CL: Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide. Microbes Infect 2007;9:1299-1306.
15. Foo DG, Alonso S, Phoon MC, Ramachandran NP, Chow VT, and Poh CL: Identification of neutralizing linear epitopes from the VP1 capsid protein of enterovirus 71 using synthetic peptides. Virus Res 2007;125:61-68.
16. Gao Y, Wang C, and Splitter GA: Mapping T- and B-lymphocyte epitopes of bovine herpesvirus-1 glycoprotein B. J Gen Virol 1999;80:2699-2704.
17. Gao FG, Khammanivong V, Liu WJ, Leggatt GR, Frazer IH, and Fernando GJ: Antigen-specific CD4+ T-cell help is required to activate a memory CD8+ T cell to a fully functional tumor killer cell. Cancer Res 2002;62:6438-6441.
18. Graham S, Wang EC, Jenkins O, and Borysiewicz LK: Analysis of the human T-cell response to picornaviruses: identification of T-cell epitopes close to B-cell epitopes in poliovirus. J Virol 1993;67:1627-1637.
19. Hagiwara A, Tagaya I, and Yoneyama T: Epidemic of hand, foot and mouth disease associated with enterovirus 71 infection. Intervirology 1978;9:60-63.
20. Hammer J, Bono E, Gallazzi F, Belunis C, Nagy Z, and Sinigaglia F: Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning. J Exp Med 1994;180:2353-2358.
21. Hammer J, Sturniolo T, and Sinigaglia F: HLA class IIpeptide binding specificity and autoimmunity. Adv Immunol 1997;66:67-100.
22. Katrak K, Mahon BP, Minor PD, and Mills KH: Cellular and humoral immune responses to poliovirus in mice: a role for helper T cells in heterotypic immunity to poliovirus. J Gen Virol. 1991;72:1093-1098.
23. Kutubuddin M, Simons J, and Chow M: Identification of T-helper epitopes in the VP1 capsid protein of poliovirus. J Virol 1992;66:3042-3047.
24. Lennette EH, and Schmidt NJ: Diagnostic Procedures for Viral and Rickettsial Infections, 4th ed. Broadway. New York, 1969.
25. Lin TY, Chu C, and Chiu CH: Lactoferrin inhibits enterovirus 71 infection of human embryonal rhabdomyosarcoma cells in vitro. J Infect Dis 2002;186:1161-1164.
26. Lu WW, Hsu YY, Yang JY, and Kung SH: Selective inhibition of enterovirus 71 replication by short hairpin RNAs. Biochem Biophys Res Commun 2004;325:494-499.
27. Mahon BP, Katrak K, and Mills KH: Antigenic sequences of poliovirus recognized by T cells: serotype-specific epitopes on VP1 and VP3 and cross-reactive epitopes on VP4 defined by using CD4+ T-cell clones. J Virol 1992;66:7012-7020.
28. Manici S, Sturniolo T, Imro MA, et al.: Melanoma cells present a MAGE-3 epitope to CD4+ cytotoxic T cells in association with histocompatibility leukocyte antigen DR11. J Exp Med 1999;189:871-876.
29. Minor PD: Antigenic structure of picornaviruses. Curr Top Microbiol Immunol 1990;161:121-154.
30. Novak EJ, Masewicz SA, Liu AW, Lernmark A, Kwok WW, and Nepom GT: Activated human epitope-specific T cells identified by class II tetramers reside within a CD4+ high, proliferating subset. Int Immunol 2001;13:799-806.
31. Oftung F, Lundin KEA, Geluk A, Shinnick TM, Meloen R, and Mustafa AS: Primary structure and MHC restriction of peptide defined T-cell epitopes from recombinantly expressed mycobacterial protein antigens. Med Principles Pract 1997;6:66-73.
32. Ossendorp F, Mengedé E, Camps M, Filius R, and Melief CJ: Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors. J Exp Med 1998;187:693-702.
33. Palacios G, and Oberste MS: Enteroviruses as agents of emerging infectious diseases. J Neurovirol 2005;11:424-433.
34. Panigada M, Sturniolo T, Besozzi G, Boccieri MG, Sinigaglia F, Grassi GG, and Grassi F: Identification of a promiscuous T-cell epitope in Mycobacterium tuberculosis Mce proteins. Infect Immun 2002;70:79-85.
35. Ravn P, Demissie A, Eguale T, et al.: Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J Infect Dis 1999;179:637-645.
36. Sanders SA, Herrero LJ, McPhie K, Chow SS, Craig ME, Dwyer DE, Rawlinson W, and McMinn PC: Molecular epidemiology of enterovirus 71 over two decades in an Australian urban community. Arch Virol 2006;151:1003-1013.
37. Schmidt NJ, Lennette EH, and Ho HH: An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis 1974;129:304-309.
38. Shih SR, Tsai KN, Li YS, Chueh CC, and Chan EC: Inhibition of enterovirus 71-induced apoptosis by allophycocyanin isolated from a blue-green alga Spirulina platensis. J Med Virol 2003;70:119-125.
39. Simons J, Kutubuddin M, and Chow M: Characterization of poliovirus-specific T lymphocytes in the peripheral blood of Sabin-vaccinated humans. J Virol 1993;67:1262-1268.
40. Snapper CM, and Mond JJ: Towards a comprehensive view of immunoglobulin class switching. Immunol Today 1993;14:15-17.
41. Tan CS, and Cardosa MJ: High-titred neutralizing antibodies to human enterovirus 71 preferentially bind to the N-terminal portion of the capsid protein VP1. Arch Virol 2007;152:1069-1073.
42. Tsuji K, Aizawa M, and Sasazuki T: HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford University Press, New York, 1992.
43. Vordermeier HM, Whelan AO, Cockle PJ, Farrant L, Palmer N, and Hewinson RG: Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle. Clin Diagn Lab Immunol 2001;8:571-578.
44. Vordermeier M, Whelan AO, and Hewinson RG: Recognition of mycobacterial epitopes by T cells across mammalian species and use of a program that predicts human HLA-DR binding peptides to predict bovine epitopes. Infect Immun 2003;71:1980-1987.
45. Wang KG, Sun LZ, Jubelt B, and Waltenbaugh C: Cell-mediated immune responses to poliovirus. I. Conditions for induction, characterization of effector cells, and cross-reactivity between serotypes for delayed hypersensitivity and T-cell proliferative responses. Cell Immunol 1989;119:252-262.
46. Wu CN, Lin YC, Fann C, Liao NS, Shih SR, and Ho MS: Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 2001;20:895-904.
47. Yu CK, Chen CC, Chen CL, Wang JR, Liu CC, Yan JJ, and Su IJ: Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice. J Biomed Sci 2000;7:523-528.